CYP1A1 Ile462Val Polymorphism and the Risk of Non-Small Cell Lung Cancer in a Chinese Population

Owonikoko T.K. , Ragin C.C. , Belani C.P. , Oton A.B. , Gooding W.E. , Taioli E. , Ramalingam S.S. : Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol, 25: 5570–5577, 2007.

Sher T. , Dy G.K. , Adjei A.A. : Small cell lung cancer. Mayo Clin Proc 83: 355–367, 2008.

Chappell D.B. , Restifo N.P. : T cell-tumor cell: a fatal interaction? Cancer Immunol Immunother, 47: 65–71, 1998.

Yu P. , Fu Y.X. : Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 86: 231–245, 2006.

Gibbons D.L. , Byers L.A. , Kurie J.M. : Smoking, p53 mutation, and lung cancer. Mol Cancer Res, 12: 3–13, 2014.

Melo-Filho C.C. , Braga R.C. , Andrade C.H. : Advances in methods for predicting phase I metabolism of polyphenols. Curr Drug Metab, 15: 120–126, 2014.

Kang J.Y. , Ryu S.H. , Park S.H. , Cha G.S. , Kim D.H. , Kim K.H. , Hong A.W. , Ahn T. , Pan J.G. , Joung Y.H. , Kang H.S. , Yun C.H. : Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs. Biotechnol Bioeng, 111: 1313–1322, 2014.

Nebert D.W. , Shi Z. , Galvez-Peralta M. , Uno S. , Dragin N. : Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences — CYP1 knockout mouse lines as a paradigm. Mol Pharmacol, 84: 304–313, 2013.

Shimada T. , Yun C.H. , Yamazaki H. , Gautier J.C. , Beaune P.H. , Guengerich F.P. : Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol, 41: 856–864, 1992.

Bartsch H. , Petruzzelli S. , De Flora S. , Hietanen E. , Camus A.M. , Castegnaro M. , Alexandrov K. , Rojas M. , Saracci R. , Giuntini C. : Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case-control multicenter study on lung cancer patients. Environ Health Perspect, 98: 119–124, 1992.

Paine A.J. : The cytochrome P450 gene superfamily. Int J Exp Pathol 72: 349–363, 1991.

Hachey D.L. , Dawling S. , Roodi N. , Parl F.F. : Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism. Cancer Res, 63: 8492–8499, 2003.

Crofts F. , Cosma G.N. , Currie D. , Taioli E. , Toniolo P. , Garte S.J. : A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis, 14: 1729–1731, 1993.

Smith G.B. , Harper P.A. , Wong J.M. , Lam M.S. , Reid K.R. , Petsikas D. , Massey T.E. : Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol Biomarkers Prev, 10: 839–853, 2001.

Huang M. , Chen Q. , Xiao J. , Zhao X. , Liu C. : CYP1A1 Ile462Val is a risk factor for ovarian cancer development. Cytokine, 58: 73–78, 2012.

Pereira Serafim P.V. , Cotrim Guerreiro da Silva I.D. , Manoukias Forones N. : Relationship between genetic polymorphism of CYP1A1 at codon 462 (Ile462Val) in colorectal cancer. Int J Biol Markers, 23: 18–23, 2008.

Lira M.G. , Provezza L. , Malerba G. , Naldi L. , Remuzzi G. , Boschiero L. , Forni A. , Rugiu C. , Piaserico S. , Alaibac M. , Turco A. , Girolomoni G. , Tessari G. : Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol, 15: 958–965, 2006.

Singh V. , Rastogi N. , Sinha A. , Kumar A. , Mathur N. , Singh M.P. : A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Breast Cancer Res Treat, 101: 73–81, 2007.

Doherty J.A. , Weiss N.S. , Freeman R.J. , Dightman D.A. , Thornton P.J. , Houck J.R. , Voigt L.F. , Rossing M.A. , Schwartz S.M. , Chen C. : Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev, 14: 357–366, 2005.

Larsen J.E. , Colosimo M.L. , Yang I.A. , Bowman R. , Zimmerman P.V. , Fong K.M. : Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes Control, 16: 579–585, 2005.

Sobin L.H. , Wittekind Ch (Ed.): TNM Classification of Malignant Tumours, Sixth Edition. John Wiley & Sons Inc, New York, 2002.

Akiyama T.E. , Gonzalez F.J. : Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochim Biophys Acta, 1619: 223–234, 2003.

Hecht S.S. : Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol, 3: 461–469, 2002.

Garte S. , Gaspari L. , Alexandrie A.K. , Ambrosone C. , Autrup H. , Autrup J.L. , Baranova H. , Bathum L. , Benhamou S. , Boffetta P. , Bouchardy C. , Breskvar K. , Brockmoller J. , Cascorbi I. , Clapper M.L. , Coutelle C. , Daly A. , Dell'Omo M. , Dolzan V. , Dresler C.M. , Fryer A. , Haugen A. , Hein D.W. , Hildesheim A. , Hirvonen A. , Hsieh L.L. , Ingelman-Sundberg M. , Kalina I. , Kang D. , Kihara M. , Kiyohara C. , Kremers P. , Lazarus P. , Le Marchand L. , Lechner M.C. , van Lieshout E.M. , London S. , Manni J.J. , Maugard C.M. , Morita S. , Nazar-Stewart V. , Noda K. , Oda Y. , Parl F.F. , Pastorelli R. , Persson I. , Peters W.H. , Rannug A. , Rebbeck T. , Risch A. , Roelandt L. , Romkes M. , Ryberg D. , Salagovic J. , Schoket B. , Seidegard J. , Shields P.G. , Sim E. , Sinnet D. , Strange R.C. , Stücker I. , Sugimura H. , To-Figueras J. , Vineis P. , Yu M.C. , Taioli E. : Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10: 1239–1248, 2001.

Yang X.R. , Wacholder S. , Xu Z. , Dean M. , Clark V. , Gold B. , Brown L.M. , Stone B.J. , Fraumeni JF Jr , Caporaso N.E. : CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett, 214: 197–204, 2004.

Molina J.R. , Yang P. , Cassivi S.D. , Schild S.E. , Adjei A.A. : Nonsmall cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc, 83: 584–594, 2008.

Kawajiri K. , Nakachi K. , Imai K. , Hayashi S. , Watanabe J. : Individual differences in lung cancer susceptibility in relation to polymorphisms of P-450IA1 gene and cigarette dose. Princess Takamatsu Symp, 21: 55–61, 1990.

Chang B.L. , Zheng S.L. , Isaacs S.D. , Turner A. , Hawkins G.A. , Wiley K.E. , Bleecker E.R. , Walsh P.C. , Meyers D.A. , Isaacs W.B. , Xu J. : Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer, 106: 375–378, 2003.

Li H. , Xiao D. , Hu L. , He T. : Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis. Mol Biol Rep, 39: 10273–10284, 2012.

Cote M.L. , Yoo W. , Wenzlaff A.S. , Prysak G.M. , Santer S.K. , Claeys G.B. , Van Dyke A.L. , Land S.J. , Schwartz A.G. : Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis, 30: 626–635, 2009.

Yoon K.A. , Kim J.H. , Gil H.J. , Hwang H. , Hwangbo B. , Lee J.S. : CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer, 60: 40–46, 2008.

Lucas D. , Menez C. , Floch F. , Gourlaouen Y. , Sparfel O. , Joannet I. , Bodénez P. , Jezequel J. , Gouérou H. , Berthou F. , Bardou L.G. , Ménez J.F. : Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians. Alcohol Clin Exp Res, 20: 1033–1037, 1996.

Hung H.C. , Chuang J. , Chien Y.C. , Chern H.D. , Chiang C.P. , Kuo Y.S. , Hildesheim A. , Chen C.J. : Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev, 6: 901–905, 1997.

Kitamura H. , Yazawa T. , Okudela K. , Shimoyamada H. , Sato H. : Molecular and genetic pathogenesis of lung cancer: differences between small-cell and non-small-cell carcinomas. Open Pathol J, 2: 9, 2008.

Kaye F.J. : RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene, 21: 6908–6914, 2002.

Toh C.K. , Gao F. , Lim W.T. , Leong S.S. , Fong K.W. , Yap S.P. , Hsu A.A. , Eng P. , Koong H.N. , Thirugnanam A. , Tan E.H. : Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers. Lung Cancer, 56: 161–166, 2007.

Ji Y.N. , Wang Q. , Suo L.J. : CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis. PLoS One, 7: e43397, 2012.

Roth M.D. , Marques-Magallanes J.A. , Yuan M. , Sun W. , Tashkin D.P. , Hankinson O. : Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am J Respir Cell Mol Biol, 24: 339–344, 2001.

Anttila S. , Raunio H. , Hakkola J. : Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesis. Am J Respir Cell Mol Biol, 44: 583–590, 2011.

Oyama T. , Uramoto H. , Kagawa N. , Yoshimatsu T. , Osaki T. , Nakanishi R. , Nagaya H. , Kaneko K. , Muto M. , Kawamoto T. , Tanaka F. , Gotoh A. : Cytochrome P450 in non-small cell lung cancer related to exogenous chemical metabolism. Front Biosci (Schol Ed) 4: 1539–1546, 2012.

London S.J. , Daly A.K. , Leathart J.B. , Navidi W.C. , Carpenter C.C. , Idle J.R. : Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis, 18: 1203–1214, 1997.

Xu X. , Kelsey K.T. , Wiencke J.K. , Wain J.C. , Christiani D.C. : Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 5: 687–692, 1996.